Skip to main content
# العنوان سنة البحث
381 Does the dihydropyridines modify the anticonvulsant action of sodium valproate? 2001
382 A selective phosphodiesterase IV inhibitor, rolipram blocks both withdrawal behavioral manifestations, and c-Fos protein expression in morphine dependent mice. 2001
383 N6-cyclohexyladenosine and 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid enhance the effect of antiepileptic drugs against induced seizures in mice 2001
384 Modulation of the anticonvulsant action of valproic acid by verapamil against pertylentetrazol-induced seizures in mice. 2001
385 Effect of Lidocaine on the anticonvulsant properties of valproic acid against convulsions elicited by pentylenetetrazol in mice. 2001
386 Pharmacotherapy of rheumatoid arthritis: an overview

2001
387 The myoneural effects of Lithium chloride on the nerve-muscle preparations of rats. Role of adenosine triphosphate-sensitive potassium channels 2000
388 Influence of sodium channel blockade on the anticonvulsant properties of sodium valproate against kainic acid-induced convulsions in mice. 2000
389 Assessment of liver function by the MEGX test in patients with schistosomiasis and cirrhosis.

1999
390 Once versus twice daily administration of amikacin in pediatric patients with bronchopneumonia: plasma drug concentration and Bayesian pharmacokinetic estimation. 1999